Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications

Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications

Oxidative phosphorylation (OXPHOS) takes place in mitochondria and is the process whereby cells use carbon fuels and oxygen to generate ATP. Formerly OXPHOS was thought to be reduced in tumours and that glycolysis was the critical pathway for generation of ATP but it is now clear that OXPHOS, at lea...

Bibliografske podrobnosti
Main Authors:	Greene, J, Segaran, A, Lord, S
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2022

Podobne knjige/članki

Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS.
od: Vivian Chen, et al.
Izdano: (2012-01-01)

OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
od: Amal Kamal Abdel-Aziz
Izdano: (2024-11-01)

Impaired OXPHOS complex III in breast cancer.
od: Kjerstin M Owens, et al.
Izdano: (2011-01-01)

The molecular evolutionary dynamics of oxidative phosphorylation (OXPHOS) genes in Hymenoptera
od: Yiyuan Li, et al.
Izdano: (2017-12-01)

The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium
od: Erna Mitaishvili, et al.
Izdano: (2024-03-01)

Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
od: Chia-Lin Chen, et al.
Izdano: (2021-04-01)

Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
od: Sonia Alcalá, et al.
Izdano: (2024-01-01)

Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects
od: Gang Cheng, et al.
Izdano: (2021-06-01)

Mitoribosomal regulation of OXPHOS biogenesis in plants
od: Hanna eJanska, et al.
Izdano: (2014-03-01)

CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
od: Viktoria Fuhr, et al.
Izdano: (2022-12-01)

Bayesian classification of OXPHOS deficient skeletal myofibres.
od: Jordan Childs, et al.
Izdano: (2025-02-01)

Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
od: Margaret AM Nelson, et al.
Izdano: (2021-06-01)

Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer
od: Shruthi Sriramkumar, et al.
Izdano: (2022-05-01)

Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
od: Isabelle Adant, et al.
Izdano: (2022-09-01)

Data mining of PubChem bioassay records reveals diverse OXPHOS inhibitory chemotypes as potential therapeutic agents against ovarian cancer
od: Sejal Sharma, et al.
Izdano: (2024-10-01)

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
od: Jayshree Hirpara, et al.
Izdano: (2019-07-01)

HADHA Regulates Respiratory Complex Assembly and Couples FAO and OXPHOS
od: Chaoying Qin, et al.
Izdano: (2024-12-01)

PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
od: Roberta Filograna, et al.
Izdano: (2024-04-01)

Bacterial muropeptides promote OXPHOS and suppress mitochondrial stress in mammals
od: Dong Tian, et al.
Izdano: (2024-04-01)

Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types
od: Ilya N. Boykov, et al.
Izdano: (2023-10-01)

A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity.
od: Janet H C Yeo, et al.
Izdano: (2015-01-01)

Tailoring nostoclide structure to target the chloroplastic electron transport chain
od: Luiz C. A. Barbosa, et al.
Izdano: (2011-11-01)

Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model
od: Patries Herst, et al.
Izdano: (2024-05-01)

Genetic and pharmacological targeting of HINT2 promotes OXPHOS to alleviate inflammatory responses and cell necrosis in acute pancreatitis
od: Jiaqi Yao, et al.
Izdano: (2025-02-01)

Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer
od: Aditi Sharma, et al.
Izdano: (2023-01-01)

Transcriptomic signals of mitochondrial dysfunction and OXPHOS dynamics in fast-growth chicken
od: Shawna Hubert, et al.
Izdano: (2022-05-01)

TFAM’s Contributions to mtDNA Replication and OXPHOS Biogenesis Are Genetically Separable
od: Natalya Kozhukhar, et al.
Izdano: (2022-11-01)

Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation
od: Eldris Iglesias, et al.
Izdano: (2019-11-01)

Attenuates of NAD+ impair BMSC osteogenesis and fracture repair through OXPHOS
od: Boer Li, et al.
Izdano: (2022-02-01)

Editorial: Mitochondrial OXPHOS System: Emerging Concepts and Technologies and Role in Disease
od: Erika Fernández-Vizarra, et al.
Izdano: (2022-05-01)

Increased oxygen consumption and OXPHOS potential in superhealer mesenchymal stem cells
od: Hughey Curtis C, et al.
Izdano: (2012-06-01)

Selection and Characterization of Palmitic Acid Responsive Patients with an OXPHOS Complex I Defect
od: Tom E. J. Theunissen, et al.
Izdano: (2017-10-01)

Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models
od: Daan F. Boreel, et al.
Izdano: (2024-11-01)

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
od: Bernd Schöpf, et al.
Izdano: (2020-03-01)

Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
od: Chun Chen, et al.
Izdano: (2021-05-01)

OXPHOS supercomplexes as a hallmark of the mitochondrial phenotype of adipogenic differentiated human MSCs.
od: Andreas D Hofmann, et al.
Izdano: (2012-01-01)

Mechanical instability generated by Myosin 19 contributes to mitochondria cristae architecture and OXPHOS
od: Peng Shi, et al.
Izdano: (2022-05-01)

Are Escherichia coli OXPHOS complexes concentrated in specialized zones within the plasma membrane?
od: Lenn, T, et al.
Izdano: (2008)

Mutations in TIMM50 compromise cell survival in OxPhos‐dependent metabolic conditions
od: Aurelio Reyes, et al.
Izdano: (2018-09-01)

Challenges in Cancer Molecular Targets and Therapeutics
od: Yisong eWang, et al.
Izdano: (2011-05-01)